Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
PRICE T ROWE ASSOCIATES INC /MD/ BROS Dutch Bros Inc. 13G 6% 6mo
RIVERNORTH CAPITAL MANAGEMENT, LLC RDAC Rising Dragon Acquisition Corp. 13G/A 8.31% 6mo
Caledonia (Private) Investments Pty Ltd ZG Zillow Group, Inc. 13G/A 26.8% 6mo
Anson Funds Management LP IMPP Imperial Petroleum Inc./Marshall Islands 13G/A 7.8% 6mo
LAZARD ASSET MANAGEMENT LLC TWN Taiwan Fund Inc 13G 16.3% 6mo
Cormorant Asset Management, LP AGMB AgomAb Therapeutics NV 13G 5.01% 6mo
1607 Capital Partners, LLC JOF Japan Smaller Capitalization Fund Inc 13G/A 12.65% 6mo
Saba Capital Management, L.P. TASK TaskUs, Inc. 13G/A 5.72% 6mo
RIVERNORTH CAPITAL MANAGEMENT, LLC MQY Blackrock Muniyield Quality Fund, Inc. 13G 5.25% 6mo
Discerene Group LP SABR Sabre Corp 13G/A 9.9% 6mo
ARMISTICE CAPITAL, LLC CLDI Calidi Biotherapeutics, Inc. 13G 9.99% 6mo
Oasis Management Co Ltd. MTN Vail Resorts Inc 13G/A 7.9% 6mo
ARMISTICE CAPITAL, LLC MGNX Macrogenics Inc 13G/A 9.46% 6mo
Point72 Asset Management, L.P. IPSC Century Therapeutics, Inc. 13G/A 3.3% 6mo
Nantahala Capital Management, LLC NSPR InspireMD, Inc. 13G/A 9.99% 6mo
BIOTECHNOLOGY VALUE FUND L P IMA ImageneBio, Inc. 13G/A 9.9% 6mo
WELLINGTON MANAGEMENT GROUP LLP HBAN Huntington Bancshares Inc 13G 6.4% 6mo
Bay Pond Partners, L.P. FSUN Firstsun Capital Bancorp 13G/A 4.4% 6mo
ARMISTICE CAPITAL, LLC HCWB HCW Biologics Inc. 13G/A 4.99% 6mo
PERCEPTIVE ADVISORS LLC SABS SAB Biotherapeutics, Inc. 13G/A 8.4% 6mo
ORBIMED ADVISORS LLC FBRX Forte Biosciences, Inc. 13G/A 4.3% 6mo
Alger Associates, Inc. 13-3017981 FBRX Forte Biosciences, Inc. 13G/A 10.2% 6mo
ADAR1 Capital Management, LLC IKT Inhibikase Therapeutics, Inc. 13G/A 9.9% 6mo
First Light Asset Management, LLC TLSI TriSalus Life Sciences, Inc. 13G 8.75% 6mo
Orbis Investment Management Limited RXO RXO, Inc. 13G/A 21.1% 6mo
BAKER BROS. ADVISORS LP GRAL GRAIL, Inc. 13G/A 9.8% 6mo
WHITEBOX ADVISORS LLC ELBM Electra Battery Materials Corp 13G/A 9.9% 6mo
Kynam Capital Management, LP CLDX Celldex Therapeutics, Inc. 13G/A 8.77% 6mo
NORWEST VENTURE PARTNERS XIII, LP TALK Talkspace, Inc. 13G/A 0% 6mo
Anson Funds Management LP DCX Digital Currency X Technology Inc. 13G/A 0% 6mo
Anson Funds Management LP LAES SEALSQ Corp 13G 5.6% 6mo
Vestal Point Capital, LP NRIX Nurix Therapeutics, Inc. 13G 6.3% 6mo
Woodline Partners LP BRCB Black Rock Coffee Bar, Inc. 13G 5.5% 6mo
RA CAPITAL MANAGEMENT, L.P. IVVD Invivyd, Inc. 13G/A 7% 6mo
Bay Pond Partners, L.P. RWT Redwood Trust Inc 13G/A 3.6% 6mo
Lingke Wang LIFE Ethos Technologies Inc. 13G 17.5% 6mo
Polar Asset Management Partners Inc. ARTC Art Technology Acquisition Corp. 13G 5.7% 6mo
Squadron Capital Management LLC LPCN Lipocine Inc. 13G/A 6.2% 6mo
Nantahala Capital Management, LLC FOXF Fox Factory Holding Corp 13G/A 3.55% 6mo
T. Rowe Price Investment Management, Inc. OS OneStream, Inc. 13G/A 0% 6mo
NOMURA HOLDINGS INC TOON Kartoon Studios, Inc. 13G 5.8% 6mo
David S. Rosenblatt DIBS 1stdibs.com, Inc. 13G/A 9.8% 6mo
Alyeska Investment Group, L.P. XAIR Beyond Air, Inc. 13G/A 0% 6mo
WELLINGTON MANAGEMENT GROUP LLP MBUU Malibu Boats, Inc. 13G/A 7.5% 6mo
Apollo Management Holdings GP, LLC CYH Community Health Systems Inc 13G/A 8.2% 6mo
Driehaus Capital Management LLC CRNX Crinetics Pharmaceuticals, Inc. 13G/A 6.11% 6mo
METEORA CAPITAL, LLC YCY AA Mission Acquisition Corp. II 13G/A 6.59% 6mo
Bay Pond Partners, L.P. ISTR Investar Holding Corp 13G/A 3.8% 6mo
ARMISTICE CAPITAL, LLC KURA Kura Oncology, Inc. 13G/A 4.23% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ TDW Tidewater Inc 13G/A 6.5% 6mo